|
RNF14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.976800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.128040E-02 |
| Normal-vs-Stage2 |
6.725800E-01 |
| Normal-vs-Stage3 |
9.263600E-01 |
| Normal-vs-Stage4 |
4.335000E-01 |
| Stage1-vs-Stage2 |
3.818800E-01 |
| Stage1-vs-Stage3 |
3.062800E-01 |
| Stage1-vs-Stage4 |
5.623600E-01 |
| Stage2-vs-Stage3 |
8.154400E-01 |
| Stage2-vs-Stage4 |
9.186200E-01 |
| Stage3-vs-Stage4 |
7.066400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.999500E-03 |
| Normal-vs-AfricanAmerican |
3.857800E-01 |
| Normal-vs-Asian |
6.467200E-01 |
| Caucasian-vs-AfricanAmerican |
1.345200E-01 |
| Caucasian-vs-Asian |
4.394400E-01 |
| AfricanAmerican-vs-Asian |
5.594800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.864500E-03 |
| Normal-vs-Female |
3.716200E-01 |
| Male-vs-Female |
1.076590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.766160E-01 |
| Normal-vs-Extreme_Weight |
1.463930E-03 |
| Normal-vs-Obese |
1.343170E-01 |
| Normal-vs-Extreme_Obese |
9.938800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.550200E-01 |
| Normal_Weight-vs-Obese |
9.888600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.119600E-01 |
| Extreme_Weight-vs-Obese |
1.901230E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.842800E-01 |
| Obese-vs-Extreme_Obese |
5.050200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.711820E-02 |
| Normal-vs-Age(41-60Yrs) |
6.680100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.090100E-02 |
| Normal-vs-Age(81-100Yrs) |
4.394300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.764440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.696200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.740000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.578000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.027400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.474800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.25479999999001E-05 |
| Normal-VS-Type2 PRCC |
1.133770E-01 |
| Normal-VS-KIRP CIMP |
2.6865000002374E-07 |
| Normal-VS-Unclassified PRCC |
9.205600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.88979999999894E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.179920E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.949700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.12809999622365E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
6.876900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.259900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.123800E-01 |
| Normal-vs-N1 |
2.922400E-01 |
| Normal-vs-N2 |
3.661600E-03 |
| N0-vs-N1 |
8.678000E-01 |
| N0-vs-N2 |
3.383200E-01 |
| N1-vs-N2 |
3.123000E-01 |
|
|
